Efficacy and Safety of Crisaborole Topical Ointment, 2%, a Novel, Nonsteroidal, Topical, Anti-Inflammatory, Phosphodiesterase Inhibitor in 2 Phase 3 Studies in Children and Adults with Mild-to-Moderate Atopic Dermatitis

Authors

Andrea Zaenglein MD, Lehigh Valley Health Network

Publication/Presentation Date

2-2016

Volume

137

Issue

2

First Page

397

Last Page

397

Published In/Presented At

https://doi.org/10.1016/j.jaci.2015.12.1230

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine Faculty

Document Type

Article